Global aptamers market to reach USD 401.5 million by 2027. Global aptamers market is valued approximately at USD 128.3 million in 2020 and is anticipated to grow with a healthy growth rate of about 17.7% over the forecast period 2021-2027. Aptamers refer to single-stranded oligonucleotides that can fold into defined architectures and also bind to targets like proteins. During the process of binding proteins, these often inhibits interactions of protein - protein and thereby can elicit therapeutic effects such as antagonism. The global aptamers market is being driven by investments in pharmaceutical research and development and rising prevalence of chronic and rare diseases. Furthermore, venture capital fundingwill provide new opportunities for the global aptamers industry. According to Statista, the total spending on pharmaceutical research and development across the globe is expected to increase from USD 137 billion in 2012 to USD 200 billion in 2020. Such growth in the pharmaceutical research and development spending across the globe is expected to increase the demand and adoption of aptamers as these are used as biological receptors in test systems, assays, or biosensors to measure these pharmaceuticals in solutions. Hence, this is expected to promote the market growth. However, low market acceptance as compared to antibodies may impede market growth over the forecast period of 2021-2027.
The regional analysis of the global aptamers market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America accounts for the largest share in terms of market revenue in the global aptamers market over the forecast period 2021-2027. Factors such as development of innovative technologies, presence of prominent market players, rising research and development activities, etc. contribute towards the largest market share of the region in the forecast years.
Major market player included in this report are:
Aptamer Group
Raptamer Discovery Group
SomaLogic Inc.
Aptagen, LLC
Maravai Lifesciences
Kaneka Corporation
NeoVentures Biotechnology Inc.
Aptus Biotech
Base Pair Biotechnologies
AMSBIO
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Type:
DNA Aptamers
XNA Aptamers
RNA Aptamers
By Technology:
SELEX
Others
By Application:
Therapeutics Development
Research & Development
Diagnostic
Others
By End User:
Pharmaceutical & Biotechnology Companies
Academic & Government Research Institutes
CROs
Others
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World
Furthermore, years considered for the study are as follows:
Historical year - 2018, 2019
Base year - 2020
Forecast period - 2021 to 2027.
Target Audience of the Global Aptamers Market in Market Study:
Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors
